These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10097588)

  • 1. Effect of age on urinary excretion of N-acetyl-beta-D-glucosaminidase.
    Oba K; Hirai M; Ajiro Y; Okazaki K; Sato S; Sasai K; Suzuki T; Nakano H; Metori S
    Nihon Ika Daigaku Zasshi; 1999 Feb; 66(1):33-6. PubMed ID: 10097588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary N-acetyl-beta-D-glucosaminidase and gamma-glutamyl-transpeptidase activities for evaluation of renal disturbance in patients with multiple myeloma].
    Nishimura K; Kawada M; Suehiro T; Yamano T; Hashimoto K
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1087-94. PubMed ID: 1363243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of urinary orosomucoid, N-acetyl-β-D-glucosaminidase, and albumin with blood pressure and hypertension after 7 years. The Tromsø Study.
    Brobak KM; Andreassen RM; Melsom T; Høieggen A; Norvik JV; Solbu MD
    Blood Press; 2022 Dec; 31(1):270-283. PubMed ID: 36193001
    [No Abstract]   [Full Text] [Related]  

  • 4. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
    Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
    J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of N-acetyl-beta-D-glucosaminidase and its isoenzymes in cats with urinary disease.
    Sato R; Soeta S; Syuto B; Yamagishi N; Sato J; Naito Y
    J Vet Med Sci; 2002 Apr; 64(4):367-71. PubMed ID: 12014584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary N-acetyl B glucosaminidase as an earlier marker of diabetic nephropathy and influence of low-dose perindopril/indapamide combination.
    Basturk T; Altuntaş Y; Kurklu A; Aydin L; Eren N; Unsal A
    Ren Fail; 2006; 28(2):125-8. PubMed ID: 16538969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical availability of urinary N-acetyl-beta-D-glucosaminidase index in dogs with urinary diseases.
    Sato R; Soeta S; Miyazaki M; Syuto B; Sato J; Miyake Y; Yasuda J; Okada K; Naito Y
    J Vet Med Sci; 2002 Apr; 64(4):361-5. PubMed ID: 12014583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of urinary N-acetyl-beta-D-glucosaminidase activity in geriatric cats with variable plasma creatinine concentrations with and without azotemia.
    Jepson RE; Vallance C; Syme HM; Elliott J
    Am J Vet Res; 2010 Feb; 71(2):241-7. PubMed ID: 20113234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary N-acetyl-beta-D-glucosaminidase changes in relation to age, sex, race, and diastolic and systolic blood pressure in a young adult biracial population. The Bogalusa Heart Study.
    Agirbasli M; Radhakrishnamurthy B; Jiang X; Bao W; Berenson GS
    Am J Hypertens; 1996 Feb; 9(2):157-61. PubMed ID: 8924265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between the Urinary N-acetyl-β-D-Glucosaminidase/Creatinine Ratio and Factors of the Metabolic Syndrome.
    Lee E; Lee YK; Kang HJ
    Ann Clin Lab Sci; 2018 Sep; 48(5):627-633. PubMed ID: 30373868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased excretion of urinary N-acetyl-beta-glucosaminidase in essential hypertension and its decline with antihypertensive therapy.
    Alderman MH; Melcher L; Drayer DE; Reidenberg MM
    N Engl J Med; 1983 Nov; 309(20):1213-7. PubMed ID: 6633570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased urinary N-acetyl-beta-glucosaminidase (NAG) excretion in young insulin-dependent diabetic patients.
    Lorini R; Scaramuzza A; Cortona L; Valenti G; d'Annunzio G; Melzi d'Eril GV
    Diabetes Res Clin Pract; 1995 Aug; 29(2):99-105. PubMed ID: 8591705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Microalbumin and N-acetyl-beta-D-glucosaminidase in random spot urine samples as predictors of diabetic nephropathy in the elderly non-insulin dependent diabetic patients].
    Hirai M; Nakano H; Oba K; Metori S
    Nihon Ika Daigaku Zasshi; 1997 Dec; 64(6):518-25. PubMed ID: 9436372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced renal allograft survival is related to low urinary N-acetyl-beta-D-glucosaminidase excretion during the first posttransplant month.
    Kotanko P; Margreiter R; Pfaller W
    Transplantation; 1996 Feb; 61(3):388-92. PubMed ID: 8610347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of office and ambulatory blood pressure measurements with urinary albumin and N-acetyl-beta-D-glucosaminidase excretions in essential hypertension.
    Opsahl JA; Abraham PA; Halstenson CE; Keane WF
    Am J Hypertens; 1988 Jul; 1(3 Pt 3):117S-120S. PubMed ID: 3415783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary N-acetyl-beta-D-glucosaminidase (NAG) in lupus nephritis and rheumatoid arthritis.
    Erdener D; Aksu K; Biçer I; Doğanavşargil E; Kutay FZ
    J Clin Lab Anal; 2005; 19(4):172-6. PubMed ID: 16025478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary N-acetyl-beta-glucosaminidase excretion is a marker of tubular cell dysfunction and a predictor of outcome in primary glomerulonephritis.
    Bazzi C; Petrini C; Rizza V; Arrigo G; Napodano P; Paparella M; D'Amico G
    Nephrol Dial Transplant; 2002 Nov; 17(11):1890-6. PubMed ID: 12401843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between pulse wave velocity and a marker of renal tubular damage (N-acetyl-β-D-glucosaminidase) in patients without diabetes.
    Ouchi M; Oba K; Saigusa T; Watanabe K; Ohara M; Matsumura N; Suzuki T; Anzai N; Tsuruoka S; Yasutake M
    J Clin Hypertens (Greenwich); 2015 Apr; 17(4):290-7. PubMed ID: 25664677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Change in urinary N-acetyl-β-d-glucosaminidase levels relevant to postprandial glycemic control conditions in subjects without diabetes mellitus.
    Ouchi M; Oba K; Ohara M; Igari Y; Futami-Suda S; Ishii K; Aoyama J; Onishi T; Tsunoda-Kubota M; Yamashita H; Suzuki T; Nakano H
    Clin Chim Acta; 2014 Jun; 433():88-92. PubMed ID: 24326128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The renal tubular damage marker urinary N-acetyl-β-D-glucosaminidase may be more closely associated with early detection of atherosclerosis than the glomerular damage marker albuminuria in patients with type 2 diabetes.
    Kim SR; Lee YH; Lee SG; Kang ES; Cha BS; Lee BW
    Cardiovasc Diabetol; 2017 Jan; 16(1):16. PubMed ID: 28122570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.